TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›ONTO
ONTO logo

ONTO

ONTO INNOVATION INC.

Next earnings Aug 5, 2026 · consensus $1.72 EPS, $332M rev

Last earnings +1.8% on 2026-05-05

Sell
$307.58
▼ -12.48%
$307.58▲ +211.06%
over 1Y
L $90.00H $351.45
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-12.5%
1W-10.6%
1M+10.6%
3M+42.7%
YTD+85.4%
1Y+211.1%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Sell
Quality
C-
Valuation
Overvalued
Filings
Clean
Sell
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 14 analysts
Buy

A debt-free metrology leader, but 120x earnings on falling profit and a 6.5% ROE leaves no margin for error.

P/E 120.1 · FY diluted EPS $2.78

The read

Weak on both the fundamentals and the price — little to like at the current level.

Onto Innovation is a financially pristine semiconductor metrology and inspection vendor — zero long-term debt, $346M cash (+62.5%), and a fortress 0.13x liabilities/equity ratio. The franchise is real, levered to advanced packaging and metrology for AI chips and advanced nodes, with revenue heavily concentrated in Taiwan (32%) and South Korea (28%). But the FY2026 (fiscal year ended January 3, 2026) results show the cyclical cracks: revenue grew only 1.8% to $1.01B while net income fell 32.2% to $137M and diluted EPS dropped 31.5% to $2.78. The MD&A attributes the systems softness to fewer inspection units shipped for AI advanced-packaging, and gross margin compressed from 52.2% to 49.7% on restructuring and excess/obsolete inventory write-downs.

The valuation is the core problem. At $333.76 the stock trades at 120.1x FY diluted EPS and 16.5x sales, yet it earns only a 6.5% return on equity and just delivered declining profitability. That is a multiple that demands strong, accelerating growth; instead the company posted a margin-led earnings decline. R&D spending rose 15.9% to $132M (now 13.1% of revenue), which is the right long-term move but pressures near-term operating margin (down to 13.2% from 19.0%).

Is ONTO a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Bear put spread~60d expiry
  • Long put 310 @ ~46.13 est
  • Short put 275 @ ~28.27 est
debit $1,786max +$1,714max −$1,786BE 292.14

SELL verdict, defined risk: profits into weakness down to the short strike; max loss is the net debit.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY20FY22FY23FY24FY26
Revenue$556M$1.01B$816M$987M$1.01B
Gross profit$278M$539M$420M$515M$500M
Operating income-$26.7M$237M$116M$187M$133M
Net income$31.0M$223M$121M$202M$137M
Diluted EPS$0.63$4.49$2.46$4.06$2.78
Net margin5.6%22.2%14.9%20.4%13.6%

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$15.0B
EV / EBITDA107.0
EV / Sales14.9
EV / FCF49.9
P / FCF51.0
PEG (trailing)—
Earnings yield0.9%
FCF yield2.0%

Quality & risk

ROIC (est.)5.0%
Free cash flow$300M
Total debt$0.00
Net cash$346M
Altman Z-Score35.95 safe
Piotroski F-Score4/9

Capital returns

Buyback yield0.5%
Dividend yield (est.)—
Shareholder yield0.5%
Shares Δ YoY+0.9%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Routine disclosure cadence — no material red flags in recent filings.
  1. 8-K Material agreement2026-05-21
  2. 8-K Shareholder vote2026-05-20
  3. 8-K Other event2026-05-18
  4. 8-K Earnings results2026-05-05
  5. 10-Q Quarterly report2026-05-05
  6. 8-K Material agreement2026-04-21
  7. 8-K Earnings results2026-04-16
  8. DEF 14A Proxy statement2026-04-06
  9. 10-K Annual report2026-02-24

Recent filings

all on EDGAR ↗
SDFiling2026-05-27open ↗4Period ending 2026-05-202026-05-22open ↗4Period ending 2026-05-202026-05-22open ↗4Period ending 2026-05-202026-05-22open ↗4Period ending 2026-05-202026-05-22open ↗4Period ending 2026-05-202026-05-22open ↗4Period ending 2026-05-202026-05-22open ↗8-KPeriod ending 2026-05-182026-05-21open ↗8-KPeriod ending 2026-05-202026-05-20open ↗4Period ending 2026-05-152026-05-18open ↗4Period ending 2026-05-152026-05-18open ↗8-KPeriod ending 2026-05-182026-05-18open ↗

Quality score

C-
ValueGrowthProfitHealthMom.
ValueF
GrowthF
ProfitabilityB
Financial healthA
MomentumC+
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
  • ✗P/E below 25

Fair value est.

$21.27

Overvalued -93% vs price

cheapfair valueexpensive

Modified Graham: EPS $2.78 × (8.5 + 1.5 × 0.0% growth) × 0.90 quality = 7.7× multiple. An estimate, not a price target.

90.0052-week378.45
Revenue
$1.01B
+1.8% YoY
Net margin
13.6%
ROE
6.5%
P/E
110.6

SEC fundamentals · FY 2026

'20'22'23'24'26

■ revenue · ■ net income, by fiscal year

Revenue$1.01B+1.8%
Net income$137M-32.2%
Gross profit$500M-3.0%
Operating income$133M-29.0%
Diluted EPS$2.78-31.5%
Cash & equivalents$346M+62.5%
Total assets$2.37B+11.8%
Total liabilities$267M+39.7%
Stockholders' equity$2.10B+9.1%
Gross: 49.7%Op.: 13.2%L/E: 0.13x

Frequently asked

Is ONTO INNOVATION INC. (ONTO) a buy?
ONTO currently carries a Sell rating with 3/5 conviction, derived from its latest SEC filings. A debt-free metrology leader, but 120x earnings on falling profit and a 6.5% ROE leaves no margin for error.
What is ONTO's fair value?
A Modified-Graham model based on ONTO's SEC fundamentals estimates a fair value of about $21.27. It is an estimate from reported earnings, not a price target.
Is ONTO overvalued or undervalued?
Against a Modified-Graham fair-value estimate, ONTO currently appears overvalued relative to its SEC-grounded earnings power.
What is ONTO INNOVATION INC.'s quality score?
ONTO scores 54.43117631235339/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000704532, latest 10-Q filed 2026-05-05) · EODHD · Proprietary analysis · as of 6/21/2026, 8:43:05 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:43 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-05-20
Su May
Director
Award761.00
2026-05-20
SEAMS CHRISTOPHER A
Director
Award761.00
2026-05-20
SCHWARTZ STEPHEN S
Director
Award761.00
2026-05-20
MILLER DAVID BRIAN
Director
Award761.00
2026-05-20
Lynch Susan D
Director
Award761.00
2026-05-20
Kelley Stephen Douglas
Director
Award761.00
2026-05-15
YALDAEI RAMIL
Chief Operating Officer
Tax218.00 @ $271.77$59.2K
2026-05-15
YALDAEI RAMIL
Chief Operating Officer
Tax625.00 @ $271.77$170K
2026-05-15
OH Yoon Ah
SVP, Gen Counsel & Corp Sec
Tax530.00 @ $271.77$144K

Held by tracked funds

Form 13F · SEC · quarterly
Point72 Asset ManagementSteve Cohen1.20M sh$247M
D. E. Shaw & Co.723K sh$148M
Fisher Asset ManagementKen Fisher650K sh$133M
Bridgewater AssociatesRay Dalio (founder)348K sh$71.4M
Two Sigma Investments313K sh$64.1M

As of each fund’s latest quarterly 13F — a delayed snapshot, not a live position. All tracked funds →

Earnings history

beat/miss · move
2026-05-05Miss -1.6% est▼ -4.02%8-K ↗
2026-04-16Miss -1.6% est▲ +16.82%8-K ↗
2026-02-19Miss -3.6% est▲ +0.79%8-K ↗
2025-11-06Beat +3.8% est▲ +3.06%8-K ↗
2025-08-07Miss -3.6% est▼ -2.18%8-K ↗
2025-05-08—▼ -24.84%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

Disclosed under the STOCK Act

2025-06-09Rob BresnahanSell$1.00K–$15.0KPTR ↗
2025-06-09Rob BresnahanSell$1.00K–$15.0KPTR ↗
2021-08-26Tom MalinowskiSell$1.00K–$15.0KPTR ↗
2021-03-05Tom MalinowskiSell$1.00K–$15.0KPTR ↗
2021-03-05Tom MalinowskiSell$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Vs tracked universe

compare →

1194 tracked peers · median

TENK Score54 vs 67
Revenue growth1.8% vs 7.5%
Net margin13.6% vs 10.0%
Return on equity6.5% vs 12.0%
P/E110.6 vs 26.2